Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VFC funds could be better targeted, House Health Subcmte. and witnesses suggest in June 15 testimony.

Executive Summary

VFC FUND SPENDING ON PUBLIC CLINICS, OUTREACH PROGRAMS would be a better use of resources, Rep. Towns (D.-N.Y.) suggested at a June 15 House Commerce/Health Subcommittee hearing on the Vaccines for Children federal vaccine purchase/distribution system. Towns said free vaccines are "unlikely to make a difference" in poor urban areas with low immunization rates. He estimated that VFC may cost up to $800 mil. in FY 1996.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel